PPCN announces a partner agreement with the Arizona State Pharmacy Association to introduce PPCN’s disease management program through their constituency to local employers
.........................................................
PPCN announces a partner agreement with the Mississippi State Pharmacy Association to introduce PPCN’s disease management program through their constituency to local employers.
........................................................
Newly trained users say they have been waiting for an easy to use and effective system that will track their clinical information. Welcome to PPCN!
Read more >>>........................................................
....................................................................................................................................................
The recent report endorsed by the U.S. Surgeon General sites the comprehensive systematic review of 298 research studies confirming that a clinical pharmacist directed disease management program return on investment is between 5.5 and 16.7 greater than cost. The overall average based on two decades of data was $10.7 per $1 of allocated cost.
Read through the stories of the patients, providers and customers that have been involved in our programs.
Twenty four percent of patients given a new medication by their doctor did not fill the prescription, according to a new study by researchers at Harvard University, Brigham and Women's Hospital and CVS Caremark and published this week in the American Journal of Medicine.
This January 2011 report in Heath Affairs gives a detailed explanation on how these to items can work together in concert to save your organization health care dollars.